These predictors included gender, LOS, smoking status, HBV status, hypertension, COPD status, asthma status, CKD status, diabetes, anemia, thrombopenia, ascites, pneumonia, liver cirrhosis, HE, portal vein invasion, microvascular invasion, N stage, T stage, therapy type and AFP. This evidence concerns the gene AFP and hereditary elliptocytosis.